Matching slides 303,780
Current window 199,951-199,980
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

199,951-199,980 of 303,780

filter-aware
39
The slide uses heatmaps to demonstrate genetic correlations with various phenotypes, highlighting the discovery of a signaling pathway.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
40
The slide uses a biological pathway diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
41
The slide uses a before-and-after diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
42
The slide uses a scatter plot to demonstrate a positive correlation (rho = 0.86) between CD200R1 and CD45 in KIRC (Clear cell renal carcinoma) samples.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
44
The slide outlines a standard clinical trial structure with patient inclusion criteria, study arms (Part A/B), and primary/secondary endpoints.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
45
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
46
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
47
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
48
The background features a DNA-like pattern of nucleotides (A, T, C, G).23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Beat · Financials1 hit
49
The slide uses a numbered list to communicate three strategic pillars.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
50
The table provides both absolute dollar amounts in millions and percentage of total revenue for each segment.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
51
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
52
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
53
The table breaks down S&M costs into five categories: Advertising/Brand, Personnel, Outside Services, D&A, and Facilities/OH.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
54
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
55
The slide uses a '+' notation to illustrate the integration of services.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
56
The background contains a scattered pattern of DNA nucleotides (A, T, C, G).23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
57
Uses a 'fill in the blanks' analogy to explain genetic imputation.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
58
The slide uses a numbered list format to outline key strategic pillars.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
01
Slide 1
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Setup1 hit
02
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a timeline-like structure to emphasize the multi-year duration and complexity of the drug development process.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Key TakeawaysLoop · Cost Of Inaction1 hit
06
The slide highlights two specific VC partners: Atlas Venture and Versant Ventures, showing program counts and target metrics.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
07
The slide uses a gradient-filled callout box to emphasize the proof-of-concept results.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
09
The slide uses a high-contrast green-on-dark-blue color scheme to emphasize key metrics.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
11
The slide uses a stacked bar chart to distinguish between programs with and without downstream participation.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
12
The slide provides a snapshot of the company's clinical pipeline as of June 30, 2022.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
13
The chart uses a stacked bar format to show revenue composition.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
14
The slide uses a waterfall-style annotation to show the delta between two periods for each expense category.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit